PL3555048T3 - Nowe pochodne kwasu pikolinowego i ich zastosowanie jako związki pośrednie - Google Patents

Nowe pochodne kwasu pikolinowego i ich zastosowanie jako związki pośrednie

Info

Publication number
PL3555048T3
PL3555048T3 PL17826574T PL17826574T PL3555048T3 PL 3555048 T3 PL3555048 T3 PL 3555048T3 PL 17826574 T PL17826574 T PL 17826574T PL 17826574 T PL17826574 T PL 17826574T PL 3555048 T3 PL3555048 T3 PL 3555048T3
Authority
PL
Poland
Prior art keywords
intermediates
acid derivatives
picolinic acid
new
new picolinic
Prior art date
Application number
PL17826574T
Other languages
English (en)
Inventor
Thomas Heinz
Benjamin Martin
Florian Andreas Rampf
Werner Zaugg
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL3555048T3 publication Critical patent/PL3555048T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17826574T 2016-12-19 2017-12-18 Nowe pochodne kwasu pikolinowego i ich zastosowanie jako związki pośrednie PL3555048T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662436222P 2016-12-19 2016-12-19
PCT/IB2017/058081 WO2018116139A1 (en) 2016-12-19 2017-12-18 New picolinic acid derivatives and their use as intermediates
EP17826574.0A EP3555048B1 (en) 2016-12-19 2017-12-18 New picolinic acid derivatives and their use as intermediates

Publications (1)

Publication Number Publication Date
PL3555048T3 true PL3555048T3 (pl) 2021-12-06

Family

ID=60953912

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17826574T PL3555048T3 (pl) 2016-12-19 2017-12-18 Nowe pochodne kwasu pikolinowego i ich zastosowanie jako związki pośrednie

Country Status (16)

Country Link
US (1) US10633341B2 (pl)
EP (1) EP3555048B1 (pl)
JP (1) JP7063902B2 (pl)
KR (1) KR102454635B1 (pl)
CN (1) CN110072851B (pl)
AU (1) AU2017381739B2 (pl)
CA (1) CA3044366A1 (pl)
DK (1) DK3555048T3 (pl)
ES (1) ES2891527T3 (pl)
HU (1) HUE055764T2 (pl)
IL (1) IL267042B (pl)
PL (1) PL3555048T3 (pl)
PT (1) PT3555048T (pl)
RU (1) RU2769693C2 (pl)
SI (1) SI3555048T1 (pl)
WO (1) WO2018116139A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202116312A (zh) * 2019-07-15 2021-05-01 瑞士商諾華公司 (s)—3—胺基—6—甲氧基—n—(3,3,3—三氟—2—羥基—2—甲基丙基)—5—(三氟甲基)吡啶甲醯胺配製物
WO2023109939A1 (zh) * 2021-12-17 2023-06-22 苏州晶云药物科技股份有限公司 吡啶类衍生物的晶型及其制备方法
CN115073366B (zh) * 2022-06-08 2024-08-09 都创(重庆)医药科技有限公司 一种基于微通道技术快速制备3-氯吡啶-2-甲酸的方法
CN116396213B (zh) * 2023-04-14 2024-06-14 济南大学 一种2-吡啶甲酸甲酯的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001500516A (ja) 1996-09-18 2001-01-16 ビーエーエスエフ アクチェンゲゼルシャフト ピリジン誘導体、その製造、及び有害菌類及び有害動物の防除へのその使用方法
BR9713027A (pt) 1996-11-12 2000-01-25 Novartis Ag Derivados de pirazol úteis como herbicidas
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
EP1810974A1 (en) 2006-01-18 2007-07-25 Ludwig-Maximilians-Universität München Preparation and use of magnesium amides
CN101535264B (zh) * 2006-11-08 2012-11-28 百时美施贵宝公司 吡啶酮化合物
US8461343B2 (en) 2007-03-27 2013-06-11 Sloan-Kettering Institute For Cancer Research Synthesis of thiohydantoins
DE102007022490A1 (de) 2007-05-14 2008-11-20 Ludwig-Maximilians-Universität Bisamid-Zinkbasen
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
MX2013000391A (es) * 2010-07-12 2013-03-08 Hoffmann La Roche 1-hidroxiimino-3-fenil-propanos.
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
ES2558457T3 (es) 2011-09-16 2016-02-04 Novartis Ag Compuestos heterocíclicos para el tratamiento de fibrosis quística
WO2013057711A1 (en) * 2011-10-21 2013-04-25 Novartis Ag Quinazoline derivatives as pi3k modulators
ES2732066T3 (es) 2014-06-06 2019-11-20 Astellas Pharma Inc Derivado de 2-acilaminotiazol para su uso en la prevención o el tratamiento de enfermedades de la vejiga/vías urinarias
ES2765730T3 (es) 2015-10-01 2020-06-10 Bristol Myers Squibb Co Inhibidores de biaril cinasa
US10662162B2 (en) 2016-03-25 2020-05-26 Afferent Pharmaceuticals, Inc. Pyrimidines and variants thereof, and uses therefor

Also Published As

Publication number Publication date
EP3555048B1 (en) 2021-07-07
RU2019122609A3 (pl) 2021-02-19
RU2019122609A (ru) 2021-01-19
CA3044366A1 (en) 2018-06-28
PT3555048T (pt) 2021-09-29
IL267042A (en) 2019-07-31
IL267042B (en) 2021-12-01
US10633341B2 (en) 2020-04-28
ES2891527T3 (es) 2022-01-28
EP3555048A1 (en) 2019-10-23
HUE055764T2 (hu) 2021-12-28
CN110072851A (zh) 2019-07-30
RU2769693C2 (ru) 2022-04-05
JP7063902B2 (ja) 2022-05-09
SI3555048T1 (sl) 2021-11-30
US20190345107A1 (en) 2019-11-14
JP2020502194A (ja) 2020-01-23
KR20190091460A (ko) 2019-08-06
WO2018116139A1 (en) 2018-06-28
AU2017381739B2 (en) 2020-06-11
AU2017381739A1 (en) 2019-05-30
KR102454635B1 (ko) 2022-10-17
CN110072851B (zh) 2023-06-06
DK3555048T3 (da) 2021-10-11

Similar Documents

Publication Publication Date Title
IL241601B (en) Derivatives of 4-amino-3-chloro-5-fluoro-6-(7-fluoro-h1-indol-6-yl)picolinic acids and their use as herbicides
IL258113A (en) Methods and intermediates for the preparation bile acid derivatives
IL252560A0 (en) Heterocyclic derivatives and their uses
EP3105217A4 (en) Isoquinoline derivatives and use thereof
IL256032A (en) Substituted pyridines and method of use
IL255054A0 (en) Tetrahydronephthyridinyl propionic acid derivatives and their uses
IL248529A0 (en) Palladianolide pyridine compounds and methods of use
IL258922A (en) Methods for the preparation of obeticholic acid and derivatives thereof
IL257392B (en) Pyrazolyl-substituted heteroaryls and their use as medicaments
IL259454B (en) New process and intermediates
IL267042A (en) New history of picolinic acid and their use as intermediates
EP3107540A4 (en) Polymorphs of lomitapide and its salts
DK3200779T3 (en) Novel anthranilic acid derivatives
SI3247711T1 (sl) Nove soli in polimorfi SCY-078
IL259073A (en) History of abscisic acid - converted at the 3' position
EP3263133B8 (en) Pyridinone compound and use thereof
EP3187488A4 (en) Novel amino-phenyl-sulfonyl-acetate derivative and use thereof
HK40008417A (en) New picolinic acid derivatives and their use as intermediates
LT3248976T (lt) Pakeisto pirazolil-pirazolo darinys ir jo panaudojimas kaip herbicidas
HUE050178T2 (hu) Piridinon vegyület és alkalmazása
HK1260336A1 (en) Valbenazine salts and polymorphs thereof
GB201513318D0 (en) Novel compounds and their use
HUP1500451A2 (en) Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates